FindTrial
Sign In

Clinical features and long term prognosis of bronchopulmonary dysplasia associated with Urealyticum infection

Clinical features and long term prognosis of bronchopulmonary dysplasia associated with Urealyticum infection - Clinical features and long term prognosis of bronchopulmonary dysplasia associated with Urealyticum infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082250
Enrollment
Unknown
Registered
2024-03-25
Start date
2022-10-19
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia

Interventions

Ureaplasma urealyticum positive group:No intervention
Ureaplasma urealyticum negative group:No intervention

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Gestational age < 32 weeks; (2) Meet the 2018 NICHD diagnostic criteria for BPD; (3) UU testing during pregnancy or neonatal hospitalization; (4) Complete clinical medical records

Exclusion criteria

Exclusion criteria: (1) The child has congenital heart and lung malformations and definite chromosomal diseases; (2) children give up treatment midway; (3) Family members refused to participate in the study, or lost the visit

Design outcomes

Primary

MeasureTime frame
Severity of bronchopulmonary dysplasia;—

Secondary

MeasureTime frame
Respiratory support;Length of stay;readmission;Neurodevelopment ;Physical development;—

Countries

China

Contacts

Public Contactzhaowenhao

Children's Hospital of Chongqing Medical University

845064894@qq.com+86 185 0825 6124

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026